Antipsychotics: treatment of schizophrenia and other therapeutic options

Close metadata

Recommended articles:

Cerebral hemodynamic disorders in patients with schizophrenia with concomitant metabolic syndrome. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(4):80-85

Clinical and psychopathological characteristics of patients with late-onset schizophrenia and schizophrenia-like psychoses in clusters identified by biological parameters. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(4):137-144

Clinical and psychometric characteristics of cognitive and negative disorders in schizophrenia. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(4-2):64-71

A case report of anti-NMDA receptor encephalitis with mental disturbances manifestation. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(5):142-144

Controversial issues of diagnosis and theoretical concepts of schizophrenia in childhood. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(7):17-24

Psychological concepts — design of clinical models of schizophrenia. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(7):25-31

Pharmacotherapy of schizophrenia: clinical and some age-related aspects. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(7):41-50

Clinical systematics of chronic delusional psychoses in schizophrenia and schizophrenia-spectrum pathology. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(7):65-74

Prolonged and chronic endogenous manic and manic-delusional states (psychopathology, typology, dynamics, clinic). S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(7):75-81

Melatonergic antidepressant agomelatine: augmentation of antipsychotic drugs in treatment of post-schizophrenic depression. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(8):5-12

Antipsychotics are used in the treatment of schizophrenia and other psychoses, as well as bipolar disorder, anxiety disorders, obsessive-compulsive disorder, post-traumatic stress disorder, and specific types of personality disorders. Due to better tolerability, as well as some advantages of the pharmacological profile, the second-generation antipsychotics are preferred in clinical practice. A special place among antipsychotics is taken by sulpiride, which shows the ability to improve the condition of patients with different types of mental disorders as well as with internal diseases.

Keywords:

mental disorders

schizophrenia

first-generation neuroleptics

second-generation neuroleptics

Authors:

Sivolap Iu.P.

Moskovskaia meditsinskaia akademiia im. I.M. Sechenova

List of references:

Taminga C. Antipsychotic Drugs. In: MSD Manual Professional Version, 2019; https://www.msdmanuals.com/professional/psychiatric-disorders/schizophrenia-and-related-disorders/antipsychotic-drugs
Lehman AF, Lieberman JA, Dixon LB, McGlashan TH, Miller AL, Perkins DO, Kreyenbuhl J. American Psychiatric Association; Steering Committee on Practice Guidelines. Practice guideline for the treatment of patients with schizophrenia, second edition. Am J Psychiatry. 2004;161(2 suppl):1-56.
Schatzberg A, DeBattista C. Manual of Clinical Psychopharmacology (Eight Edition). Washington, DC: American Psychiatric Publishing; 2015.
Lieberman JA, Tollefson G, Tohen M, Green AI, Gur RE, Kahn R, McEvoy J, Perkins D, Sharma T, Zipursky R, Wei H, Hamer RM. HGDH Study Group. Comparative efficacy and safety of atypical and conventional antipsychotic drugs in first-episode psychosis: a randomized, double-blind trial of olanzapine versus haloperidol. Am J Psychiatry. 2003;160(8):1396-1404. https://doi.org/10.1176/appi.ajp.160.8.1396
Semple D, Smyth R. Oxford handbook of psychiatry (third edition). Oxford: Oxford University Press; 2013.
Harrison P, Cowen P, Burns T, Fazel M. Shorter oxford textbook of psychiatry. Seventh edition. Oxford: Oxford University Press; 2018.
Spina E, de Leon J. Clinically relevant interactions between newer antidepressants and second-generation antipsychotics. Expert Opin Drug Metab Toxicol. 2014;10(5):721-746. https://doi.org/10.1517/17425255.2014.885504
Pignon B, Tezenas du Montcel C, Carton L, Pelissolo A. The place of antipsychotics in the therapy of anxiety disorders and obsessive-compulsive disorders. Curr Psychiatry Rep. 2017;19(12):103. https://doi.org/10.1007/s11920-017-0847-x
Freire RC, Zugliani MM, Garcia RF, Nardi AE. Treatment-resistant panic disorder: a systematic review. Expert Opin Pharmacother. 2016;17(2):159-168. https://doi.org/10.1517/14656566.2016.1109628
Perna G, Alessandra A, Raffaele B, Elisa M, Giuseppina D, Paolo C, Maria N, Daniela C. Is there room for second-generation antipsychotics in the pharmacotherapy of panic disorder? A systematic review based on PRISMA Guidelines. Int J Mol Sci. 2016;17(4):551;. https://doi.org/10.3390/ijms17040551
Maher AR, Theodore G. Summary of the comparative effectiveness review on off-label use of atypical antipsychotics. J Manag Care Pharm. 2012;18(5 suppl B):1-20.
Skodol A. Overview of Personality Disorders. In: MSD Manual Professional Version, 2019; https://www.msdmanuals.com/professional/psychiatric-disorders/personality-disorders/overview-of-personality-disorders
Huang CW, Chiu YW, Chen PJ, Yu NW, Tsai HJ, Chang CM. Trends and factors in antipsychotic use of outpatients with anxiety disorders in Taiwan, 2005—2013: a population-based study. Psychiatry Clin Neurosci. 2019. https://doi.org/10.1111/pcn.12861
Mosolov SN. Modern trends in the treatment of schizophrenia. eglonil place in therapy of acute and chronic psychosis. Psihiatrija i Psihofarmakoterapija. 2000;2(3):3-6. (In Russ.)
Ovsyannikov SA. Sulpiride — an atypical antipsychotic of a wide spectrum of action. Psihiatrija i Psihofarmakoterapija. 2003;5(2):72-73. (In Russ.)
Tyuvina NA, Balabanova VV, Goncharova EM. Experience in using sulpiride in non-psychotic endogenous depressive-hypochondriacal disorders. Nevrologija, Nejropsihiatrija, Psihosomatika. 2012;4(1):67-71. (In Russ.) https://doi.org/10.14412/2074-2711-2012-365
Statsenko OA, Drozdovsky YuV, Kralya OV. Sulpiride in complex therapy of agoraphobia with panic disorder. Rossijskij Psihiatricheskij Zhurnal. 2011;2:63-68. (In Russ.)
Huhn M, Nikolakopoulou A, Schneider-Thoma J, Krause M, Samara M, Peter N, Arndt T, Bäckers L, Rothe P, Cipriani A, Davis J, Salanti G, Leucht S. Comparative efficacy and tolerability of 32 oral antipsychotics for the acute treatment of adults with multi-episode schizophrenia: a systematic review and network meta-analysis. Lancet. 2019. https://doi.org/10.1016/S0140-6736(19)31135-3
Rothenberger A, Roessner V. Psychopharmacotherapy of obsessive-compulsive symptoms within the framework of Tourette syndrome. Curr Neuropharmacol. 2018. https://doi.org/10.2174/1570159X16666180828095131
Hsieh YH, Chan HL, Lin CF, Liang SH, Lu ML, McIntyre RS, Lee Y, Lin TC, Chiu WC, Chen VC. Antipsychotic use is inversely associated with gastric cancer risk: a nationwide population-based nested case-control study. Cancer Med. 2019. https://doi.org/10.1002/cam4.2329
Yao QY, Li J, Chen R, Yao Y, Xue JS, Chen WJ, Lu W, Zhou TY. Preclinical PK/PD model for the combinatorial use of dexamethasone and sulpiride in the treatment of breast cancer. Acta Pharmacol Sin. 2019. https://doi.org/10.1038/s41401-019-0251-7

Close metadata